This is a $4,288.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of 4,566,779,179 units of the NEXPLANON 68 MG IMPLANTS medication, with a performance period that runs through January 14, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military healthcare facilities worldwide. This particular delivery order is not associated with any set-aside designation.
Generated 3/21/25, 9:53 AM